Related Experiment Videos
Steroid treatment of an orbital or periocular hemangioma
Journal of Pediatric Ophthalmology
|January 1, 1977
Insights
Systemic prednisone rapidly resolved orbital hemangiomas in an infant. This treatment offers a potential alternative for managing this condition, preventing vision loss in infants.
Area of Science:
- Ophthalmology
- Pediatric Medicine
- Vascular Malformations
Background:
- Orbital hemangiomas are benign vascular tumors that can cause significant visual impairment in infants.
- Potential complications include strabismus (eye deviation), amblyopia (lazy eye), and loss of binocular vision.
Observation:
- A five-month-old infant presented with a rapidly growing orbital hemangioma.
- The hemangioma was causing deviation of the visual axis, posing a risk to vision development.
Findings:
- The infant was treated with systemic prednisone over a six-week period.
- Rapid and complete resolution of the orbital hemangioma was observed following treatment.
Implications:
- Systemic corticosteroid therapy, specifically prednisone, presents a promising, non-invasive treatment option for infantile orbital hemangiomas.
- Early intervention with prednisone may prevent long-term visual deficits associated with orbital hemangiomas.
Abstract:
Orbital hemangiomas may cause deviation of the visual axis with amblyopia and loss of fusion in the infant as a result. Prior methods of treatment include radiation, injection of sclerosing solutions, surgery and ligation of feeding vessels and systemic steroids. A case is presented of an infant treated at five months of age with systemic prednisone over a six-week period with rapid resolution of an orbital hemangioma.